Mubadala

Press Releases

His Highness Sheikh Tahnoon Bin Mohammed Al Nahyan Officially Opens Imperial College London Diabetes Centre in Al Ain

His Highness Sheikh Tahnoon bin Mohammed Al Nahyan, the Ruler’s Representative in the Eastern Region has officially opened the second Imperial College London Diabetes Centre - a state-of-the-art facility that will provide world-class standards of care to patients in Al Ain and the surrounding region.

28 May 2012

His Highness Sheikh Tahnoon bin Mohammed Al Nahyan, the Ruler’s Representative in the Eastern Region has officially opened the second Imperial College London Diabetes Centre - a state-of-the-art facility that will provide world-class standards of care to patients in Al Ain and the surrounding region.

The launch of this new facility follows the establishment of the first Imperial College London Diabetes Centre in Abu Dhabi in 2006 and is an extension of the partnership agreement between Mubadala Healthcare (a business unit of Mubadala Development Company) and Imperial College London, a science-based institution that is consistently rated as one of the world’s best universities.

Imperial College London Diabetes Centre (ICLDC) is founded on the four pillars of treatment, training, public health, and research, and provides the highest level of specialised and comprehensive patient care - from the first diagnosis to the management of all the complications associated with diabetes.

Dr Maha Taysir Barakat, ICLDC’s Medical & Research Director and Consultant Endocrinologist confirmed that with the opening of the Al Ain facility, ICLDC now receives more than Ten Thousands patient visits each month across the two centres.

“The opening of the second centre in Al Ain ensures many more people in the UAE have access to the world-class treatment for which Imperial College London Diabetes Centre has become known,” she said.

The facilities are highly efficient with most laboratory tests conducted on-site and a unique paperless IT system which means that all patients are given results and recommendations in one visit.

Since becoming operational in September of last year, ICLDC’s Al Ain facility has already received two endorsements from the Joint Commission International (JCI) – the JCI Certification in the Clinical Care Program for Diabetes Management and the JCI Accreditation in Ambulatory Care, both held by ICLDC’s Abu Dhabi facility since 2009 and 2010, respectively.

Imperial College London Diabetes Centre is still the only facility in the world to hold both of these certifications.

The UAE ranks tenth worldwide for the prevalence of diabetes per capita of the adult population, and recent figures from the International Diabetes Federation suggest that 19.2 per cent of the UAE adult population are living with diabetes, half of whom are unaware that they have it.

In addition to the excellent clinical care provided by the two facilities, ICLDC’s award-winning public health awareness campaign, ‘Diabetes-Knowledge-Action’ has reached out to countless others across the Emirates and the region over the past six years.

“Partnering with international expertise to address one of our region’s most pressing healthcare issues is integral to our healthcare strategy and I am delighted with the tremendous positive impact that Imperial College London Diabetes Centre has had on our community,” said Waleed Al Mokarrab Al Muhairi, Chief Operating Officer of Mubadala Development Company.

“The expansion of this proven model of care into Al Ain is a testament to ICLDC’s success to date as well as our commitment to deliver world-class healthcare to the people of Al Ain and the surrounding region.”

About Imperial College London Diabetes Centre

Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness, with two centres – one each in Abu Dhabi and Al Ain.

The purpose-built centres are an initiative of Mubadala Healthcare, in partnership with the UK’s Imperial College London. Mubadala Healthcare, a division of Mubadala Development Company, is specifically dedicated to investment in strategic, high value and economically sustainable projects that meaningfully enhance the private healthcare infrastructure of Abu Dhabi and the UAE.

The launch of ICLDC in 2006 is testament to the vision of Mubadala Healthcare to develop projects that protect and enhance the nation’s health. ICLDC has offered diabetes prevention, education and treatment to more than 100,000 people.

‘Diabetes-Knowledge-Action’ is ICLDC’s award-winning public health awareness campaign. It was launched in 2007 under the patronage of HH Sheikha Fatima bint Mubarak, in partnership with The Emirates Foundation for Philanthropy.

ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) in Diabetes Management and JCI Accreditation for Ambulatory Care. When the Centre in Abu Dhabi received the awards it became the only healthcare provider worldwide to hold both certifications and the first facility in the Middle East and third globally to hold JCI’s highly-acclaimed CCPC specifically for the clinical management of diabetes.

For more information visit www.icldc.ae